Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrari

Showing results (351-360 of 547) with videos related to

Pageof 55
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Genome-wide location analysis reveals a role for Sub1 in RNA polymerase III transcriptionArounie Tavenet, Audrey Suleau, Géraldine Dubreuil, et al.
Current Opinion in Cardiology|June 4, 2008
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapyJasper J Brugts, A H Jan Danser, Moniek P M de Maat, et al.
Journal of the American College of Cardiology|June 3, 2004
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarctionMarco Valgimigli, Elisa Merli, Patrizia Malagutti, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 20, 2022
Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot LesionsPaolo Cimaglia, Davide Bernucci, Laura Sofia Cardelli, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 1, 2022
Relationship between PCSK9 and endothelial function in patients with acute myocardial infarctionPaolo Cimaglia, Francesca Fortini, Francesco Vieceli Dalla Sega, et al.
European Journal of Preventive Cardiology|February 24, 2021
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smokingAlexandre Gautier, Gregory Ducrocq, Yedid Elbez, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
European Journal of Preventive Cardiology|January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromesEmmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
Pageof 55

Showing results (351-360 of 547) with videos related to

Sort By:
Pageof 55
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Genome-wide location analysis reveals a role for Sub1 in RNA polymerase III transcriptionArounie Tavenet, Audrey Suleau, Géraldine Dubreuil, et al.
Current Opinion in Cardiology|June 4, 2008
Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapyJasper J Brugts, A H Jan Danser, Moniek P M de Maat, et al.
Journal of the American College of Cardiology|June 3, 2004
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarctionMarco Valgimigli, Elisa Merli, Patrizia Malagutti, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 20, 2022
Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot LesionsPaolo Cimaglia, Davide Bernucci, Laura Sofia Cardelli, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 1, 2022
Relationship between PCSK9 and endothelial function in patients with acute myocardial infarctionPaolo Cimaglia, Francesca Fortini, Francesco Vieceli Dalla Sega, et al.
European Journal of Preventive Cardiology|February 24, 2021
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smokingAlexandre Gautier, Gregory Ducrocq, Yedid Elbez, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
European Journal of Preventive Cardiology|January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromesEmmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
Pageof 55